Extralymphoid CD8+ T Cells Resident in Tissue from Simian Immunodeficiency Virus SIVmac239Δnef-Vaccinated Macaques Suppress SIVmac239 Replication Ex Vivo

ABSTRACT Live-attenuated vaccination with simian immunodeficiency virus (SIV) SIVmac239Δnef is the most successful vaccine product tested to date in macaques. However, the mechanisms that explain the efficacy of this vaccine remain largely unknown. We utilized an ex vivo viral suppression assay to assess the quality of the immune response in SIVmac239Δnef-immunized animals. Using major histocompatibility complex-matched Mauritian cynomolgus macaques, we did not detect SIV-specific functional immune responses in the blood by gamma interferon (IFN-γ) enzyme-linked immunospot assay at select time points; however, we found that lung CD8+ T cells, unlike blood CD8+ T cells, effectively suppress virus replication by up to 80%. These results suggest that SIVmac239Δnef may be an effective vaccine because it elicits functional immunity at mucosal sites. Moreover, these results underscore the limitations of relying on immunological measurements from peripheral blood lymphocytes in studies of protective immunity to HIV/SIV.

[1]  L. Fritts,et al.  Limited dissemination of pathogenic SIV after vaginal challenge of rhesus monkeys immunized with a live, attenuated lentivirus. , 2009, Virology.

[2]  C. Rouzioux,et al.  Heterogeneity in HIV Suppression by CD8 T Cells from HIV Controllers: Association with Gag-Specific CD8 T Cell Responses1 , 2009, The Journal of Immunology.

[3]  Austin Hughes,et al.  Ultradeep Pyrosequencing Detects Complex Patterns of CD8+ T-Lymphocyte Escape in Simian Immunodeficiency Virus-Infected Macaques , 2009, Journal of Virology.

[4]  D. H. Young,et al.  Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control. , 2009, Blood.

[5]  S. Sieg,et al.  Faculty Opinions recommendation of Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge. , 2009 .

[6]  M. McChesney,et al.  Antiviral CD8+ T cells in the genital tract control viral replication and delay progression to AIDS after vaginal SIV challenge in rhesus macaques immunized with virulence attenuated SHIV 89.6 , 2009, Journal of internal medicine.

[7]  O. Yang.  Assessing the antiviral activity of HIV-1-specific cytotoxic T lymphocytes. , 2009, Methods in molecular biology.

[8]  D. Burton,et al.  Macaques vaccinated with live-attenuated SIV control replication of heterologous virus , 2008, The Journal of experimental medicine.

[9]  D. Lu,et al.  With Minimal Systemic T-Cell Expansion, CD8+ T Cells Mediate Protection of Rhesus Macaques Immunized with Attenuated Simian-Human Immunodeficiency Virus SHIV89.6 from Vaginal Challenge with Simian Immunodeficiency Virus , 2008, Journal of Virology.

[10]  J. Lifson,et al.  Antiretroviral Therapy prior to Acute Viral Replication Preserves CD4 T Cells in the Periphery but Not in Rectal Mucosa during Acute Simian Immunodeficiency Virus Infection , 2008, Journal of Virology.

[11]  R. Stebbings,et al.  Resistance to superinfection by a vigorously replicating, uncloned stock of simian immunodeficiency virus (SIVmac251) stimulates replication of a live attenuated virus vaccine (SIVmacC8). , 2008, The Journal of general virology.

[12]  A. Haase,et al.  Protective attenuated lentivirus immunization induces SIV-specific T cells in the genital tract of rhesus monkeys , 2008, Mucosal Immunology.

[13]  R. Desrosiers,et al.  Vaccine Protection by Live, Attenuated Simian Immunodeficiency Virus in the Absence of High-Titer Antibody Responses and High-Frequency Cellular Immune Responses Measurable in the Periphery , 2008, Journal of Virology.

[14]  R. Sékaly.  The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development? , 2008, The Journal of experimental medicine.

[15]  D. Douek,et al.  High frequencies of polyfunctional HIV-specific T cells are associated with preservation of mucosal CD4 T cells in bronchoalveolar lavage , 2008, Mucosal Immunology.

[16]  D. Watkins,et al.  Recognition of Escape Variants in ELISPOT Does Not Always Predict CD8+ T-Cell Recognition of Simian Immunodeficiency Virus-Infected Cells Expressing the Same Variant Sequences , 2007, Journal of Virology.

[17]  Z. Grossman,et al.  Progressive CD4+ central–memory T cell decline results in CD4+ effector–memory insufficiency and overt disease in chronic SIV infection , 2007, The Journal of experimental medicine.

[18]  T. Matano,et al.  Induction of CD8+ Cells Able To Suppress CCR5-Tropic Simian Immunodeficiency Virus SIVmac239 Replication by Controlled Infection of CXCR4-Tropic Simian-Human Immunodeficiency Virus in Vaccinated Rhesus Macaques , 2007, Journal of Virology.

[19]  D. Watkins,et al.  Gag-Specific CD8+ T Lymphocytes Recognize Infected Cells before AIDS-Virus Integration and Viral Protein Expression1 , 2007, The Journal of Immunology.

[20]  D. Watkins,et al.  Gag-Specific CD 8 T Lymphocytes Recognize Infected Cells before AIDS-Virus Integration and Viral Protein Expression 1 , 2007 .

[21]  D. Watkins,et al.  The Antiviral Efficacy of Simian Immunodeficiency Virus-Specific CD8+ T Cells Is Unrelated to Epitope Specificity and Is Abrogated by Viral Escape , 2006, Journal of Virology.

[22]  D. Watkins,et al.  Not All Cytokine-Producing CD8+ T Cells Suppress Simian Immunodeficiency Virus Replication , 2006, Journal of Virology.

[23]  D. O’Connor,et al.  Simian Immunodeficiency Virus SIVmac239 Infection of Major Histocompatibility Complex-Identical Cynomolgus Macaques from Mauritius , 2006, Journal of Virology.

[24]  V. Maino,et al.  IL-15 induces CD4 effector memory T cell production and tissue emigration in nonhuman primates. , 2006, The Journal of clinical investigation.

[25]  R. Le Grand,et al.  Changes in Soluble Factor-Mediated CD8+ Cell-Derived Antiviral Activity in Cynomolgus Macaques Infected with Simian Immunodeficiency Virus SIVmac251: Relationship to Biological Markers of Progression , 2006, Journal of Virology.

[26]  D. Watkins,et al.  Tat28-35SL8-Specific CD8+ T Lymphocytes Are More Effective than Gag181-189CM9-Specific CD8+ T Lymphocytes at Suppressing Simian Immunodeficiency Virus Replication in a Functional In Vitro Assay , 2005, Journal of Virology.

[27]  G. Hale,et al.  CD8+ Lymphocytes Do Not Mediate Protection against Acute Superinfection 20 Days after Vaccination with a Live Attenuated Simian Immunodeficiency Virus , 2005, Journal of Virology.

[28]  Qingsheng Li,et al.  Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells , 2005, Nature.

[29]  Mario Roederer,et al.  Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection , 2005, Nature.

[30]  O. Yang,et al.  Parallel Human Immunodeficiency Virus Type 1-Specific CD8+ T-Lymphocyte Responses in Blood and Mucosa during Chronic Infection , 2005, Journal of Virology.

[31]  Philip R. Johnson,et al.  HIV vaccine design: insights from live attenuated SIV vaccines , 2005, Nature Immunology.

[32]  A. Wade-Evans,et al.  Vaccination with live attenuated simian immunodeficiency virus for 21 days protects against superinfection. , 2004, Virology.

[33]  V. Maino,et al.  Insufficient Production and Tissue Delivery of CD4+Memory T Cells in Rapidly Progressive Simian Immunodeficiency Virus Infection , 2004, The Journal of experimental medicine.

[34]  Wayne C Koff,et al.  HIV vaccine design and the neutralizing antibody problem , 2004, Nature Immunology.

[35]  Julie Elliott,et al.  Optimization of methods to assess human mucosal T-cell responses to HIV infection. , 2003, Journal of immunological methods.

[36]  D. Nixon,et al.  Trafficking of Human Immunodeficiency Virus Type 1-Specific CD8+ T Cells to Gut-Associated Lymphoid Tissue during Chronic Infection , 2003, Journal of Virology.

[37]  M. McElrath,et al.  Ontogeny and Specificities of Mucosal and Blood Human Immunodeficiency Virus Type 1-Specific CD8+ Cytotoxic T Lymphocytes , 2003, Journal of Virology.

[38]  A. Wade-Evans,et al.  Mechanisms of protection induced by attenuated simian immunodeficiency virus. , 2002, Virology.

[39]  R. Johnson,et al.  Mechanisms of protection against simian immunodeficiency virus infection. , 2002, Vaccine.

[40]  K. Mansfield,et al.  Simian immunodeficiency virus (SIV)-specific cytotoxic T lymphocytes in gastrointestinal tissues of chronically SIV-infected rhesus monkeys. , 2001, Blood.

[41]  A. Wade-Evans,et al.  Mechanisms of protection induced by live attenuated simian immunodeficiency virus , 2001, Journal of medical primatology.

[42]  Todd M. Allen,et al.  Induction of Mucosal Homing Virus-Specific CD8+ T Lymphocytes by Attenuated Simian Immunodeficiency Virus , 2000, Journal of Virology.

[43]  D. Montefiori,et al.  Protection by Live, Attenuated Simian Immunodeficiency Virus against Heterologous Challenge , 1999, Journal of Virology.

[44]  D. Montefiori,et al.  Highly Attenuated Vaccine Strains of Simian Immunodeficiency Virus Protect against Vaginal Challenge: Inverse Relationship of Degree of Protection with Level of Attenuation , 1999, Journal of Virology.

[45]  L. Cioé,et al.  Long-lasting protection by live attenuated simian immunodeficiency virus in cynomolgus monkeys: no detection of reactivation after stimulation with a recall antigen. , 1999, Virology.

[46]  D. Ho,et al.  Temporal Analyses of Virus Replication, Immune Responses, and Efficacy in Rhesus Macaques Immunized with a Live, Attenuated Simian Immunodeficiency Virus Vaccine , 1998, Journal of Virology.

[47]  S. Cobbold,et al.  Mechanisms of protection induced by attenuated simian immunodeficiency virus. II. Lymphocyte depletion does not abrogate protection. , 1998, AIDS research and human retroviruses.

[48]  R. Means,et al.  Inhibition of Simian Immunodeficiency Virus (SIV) Replication by CD8+ T Lymphocytes from Macaques Immunized with Live Attenuated SIV , 1998, Journal of Virology.

[49]  R. Desrosiers,et al.  Protective immunity induced by live attenuated simian immunodeficiency virus. , 1998, Current opinion in immunology.

[50]  L. Chieco‐Bianchi,et al.  Live attenuated simian immunodeficiency virus prevents super-infection by cloned SIVmac251 in cynomolgus monkeys. , 1997, The Journal of general virology.

[51]  R. Stebbings,et al.  Mechanisms of protection induced by attenuated simian immunodeficiency virus. I. Protection cannot be transferred with immune serum. , 1997, The Journal of general virology.

[52]  R P Johnson,et al.  Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms , 1997, Journal of virology.

[53]  N. Almond,et al.  Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells , 1995, The Lancet.

[54]  R. Desrosiers,et al.  Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. , 1992, Science.

[55]  R. Desrosiers,et al.  Importance of the nef gene for maintenance of high virus loads and for development of AIDS , 1991, Cell.

[56]  R. Desrosiers,et al.  Comparison of simian immunodeficiency virus isolates , 1988, Nature.